Drug intelligence / Profile preview

Funbact A

Development stage
Unknown
Lead developer
Greenlife Pharmaceuticals
Modality
Small Molecules
Administration
Topical
01

Overview

Funbact A is a triple-action topical cream developed and marketed by Greenlife Pharmaceuticals. It is a combination product containing three active ingredients: betamethasone (a synthetic corticosteroid), clotrimazole (a broad-spectrum antifungal), and neomycin sulphate (an aminoglycoside antibiotic). Betamethasone provides anti-inflammatory, antipruritic, and vasoconstrictive actions to reduce skin redness and swelling. Clotrimazole acts by inhibiting the synthesis of ergosterol, an essential component of fungal cell membranes, thereby treating fungal infections. Neomycin sulphate provides antibacterial activity against a wide range of Gram-positive and Gram-negative bacteria by inhibiting protein synthesis. The cream is primarily indicated for the treatment of inflammatory dermatological conditions complicated by bacterial or fungal infections, such as eczema, psoriasis, and various forms of dermatitis.

Brand names
Funbact A
02

Targets

GR (Glucocorticoid receptor)CYP51A1 (Sterol 14α-demethylase)Bacterial Ribosome

Beyond the preview

Go deeper on Funbact A.

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Clinical trials

Full profile access

Follow clinical development from study design and recruitment through results.

  • Trial phase
  • Status
  • Readouts

Indications & development

Full profile access

Explore development by indication, patient population, and geography.

  • Indications
  • Development status
  • Countries

Licensing & deals

Full profile access

Trace asset ownership, licensing agreements, and commercial partnerships.

  • Partners
  • Deal terms
  • Milestones

Patents & exclusivity

Full profile access

Explore the patent landscape and regulatory exclusivity around an asset.

  • Patents
  • Expiration dates
  • Exclusivity

Competitive landscape

Full profile access

Compare development programs by target, modality, and indication.

  • Competing assets
  • Targets
  • Development stage

Research & analysis

Full profile access

Connect source evidence and development news to your research questions.

  • Publications
  • News
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on Funbact A.

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call